Business Services Industry
S&P Lowers First Indemnity of America Ins. Co. FSR
Business Wire, April 11, 2000
Business Editors
NEW YORK--(BUSINESS WIRE)--Standard & Poor's CreditWire--
April 11, 2000--Standard & Poor's today lowered its financial strength
rating on First Indemnity of America Insurance Co. (First Indemnity)
to single-'Bpi' from double-'Bpi'.
First Indemnity, which markets primarily through brokers,
commenced operations in 1979. It is a stock company based in
Parsippany, N.J., and licensed in seven states. With $5.8 million in
surplus in 1998, it is a very small insurer, whose major lines of
business are surety and inland marine insurance.
[pilcrow (paragraph sign)] The rating on the company is based on
stand-alone
characteristics.
Major Rating Factors:
-- At year-end 1998, capitalization was marginal, as indicated by
Standard & Poor's capital adequacy ratio of 85.3%. The company's
surplus, which was $5.8 million at year-end 1998, has declined at an
annual rate of 8.6% since 1991. In addition, for the first nine months
of 1999, surplus decreased 12% to $5.1 million, primarily as a result
of a $0.6 million net underwriting loss and $0.6 million of net
realized capital losses.
-- Operating performance has been weak, with a five-year average
return on revenue of negative 4.0%. In addition, the Standard & Poor's
earnings adequacy ratio of negative 103.0% is considered weak.
-- The company's liquidity ratio of 33.4%, in conjunction with a
reinsurance recoverable from non-affiliates to surplus of 77.3%, is
viewed as a limiting factor.
-- The company's limited business scope (79.2% of net premiums
written in New Jersey), in combination with the company's history of
erratic earnings, is viewed as unfavorable.
'pi' ratings, denoted with a 'pi' subscript, are insurer
financial strength ratings based on an analysis of an insurer's
published financial information and additional information in the
public domain. They do not reflect in-depth meetings with an insurer's
management and are therefore based on less comprehensive information
than ratings without a 'pi' subscript. 'pi' ratings are reviewed
annually based on a new year's financial statements, but may be
reviewed on an interim basis if a major event that may affect the
insurer's financial security occurs. Ratings with a 'pi' subscript are
not subject to potential CreditWatch listings.
Ratings with a 'pi' subscript generally are not modified with
'plus' or 'minus' designations. However, such designations may be
assigned when the insurer's financial strength rating is constrained
by sovereign risk or the credit quality of a parent company or
affiliated group, Standard & Poor's said. -- CreditWire.
--30--RGB/dx* SAM/dx
CONTACT: Standard & Poor's Ratings Services, New York
Polina Chernyak, 212/438-7179
KEYWORD: NEW YORK NEW JERSEY
INDUSTRY KEYWORD: BANKING INSURANCE BOND/STOCK RATINGS
COPYRIGHT 2000 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


